Overall survival of patients with advanced colorectal cancer correlates with availability of fluorouracil, irinotecan, and oxaliplatin regardless of whether doublet or single-agent therapy is used first line [11]

Axel Grothey, Daniel Sargent

Research output: Contribution to journalLetter

227 Scopus citations
Original languageEnglish (US)
Pages (from-to)9441-9442
Number of pages2
JournalJournal of Clinical Oncology
Volume23
Issue number36
DOIs
StatePublished - Dec 1 2005

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this